Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 6 6 11 146
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 1 4 10 58
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 0 0 9 129
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 0 0 2 154 4 11 34 420
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 4 10 19 693
Lies have long legs. Cheating, public scrutiny and loyalty in teams 0 0 1 44 5 6 22 180
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 1 2 2 24 7 10 27 72
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 1 1 1 17 5 6 25 53
Optimizing Tax Administration Policies with Machine Learning 0 1 2 267 2 9 29 718
R&D and market size: who benefits from orphan drug regulation? 0 0 0 76 4 5 13 209
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 0 1 3 26 0 2 23 88
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 26 5 6 26 155
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 0 89 4 5 21 149
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 2 3 12 101
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 0 72 0 1 14 134
What exactly is public in a public good game? A lab-in-the-field experiment 1 1 3 158 4 5 21 381
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 0 1 95 3 5 29 177
Total Working Papers 3 6 15 1,472 56 94 345 3,863


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An experimental manipulation of divisibility in the public good game 1 1 1 1 3 5 6 6
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 0 17 3 5 11 98
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 2 5 16 49
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 2 4 15 30
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 0 0 4 26
Machine learning and the optimization of prediction-based policies 0 0 1 6 4 8 28 38
R&D and market size: Who benefits from orphan drug legislation? 1 1 1 5 8 11 19 49
R&D investments, financing constraints, exporting and productivity 0 1 2 59 3 11 21 186
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 0 0 1 1 3 5 10 10
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 2 20 6 8 20 130
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 0 0 0 2 1 1 7 14
The impact of managed entry agreements on pharmaceutical prices 0 0 1 16 3 5 21 98
The impact of social pressure on tax compliance: A field experiment 0 0 2 28 5 5 12 139
When the two ends meet: an experiment on cooperation and social capital 0 1 2 7 2 6 24 50
Total Journal Articles 2 4 13 175 45 79 214 923


Statistics updated 2026-05-06